MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 114 filers reported holding MAXCYTE INC in Q1 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,605,751 | -32.0% | 2,117,228 | 0.0% | 0.03% | -29.3% |
| Q2 2023 | $9,718,077 | -7.3% | 2,117,228 | 0.0% | 0.04% | -21.2% |
| Q1 2023 | $10,480,279 | -29.9% | 2,117,228 | -22.7% | 0.05% | -42.9% |
| Q4 2022 | $14,947,351 | -24.4% | 2,737,610 | -10.0% | 0.09% | -27.8% |
| Q3 2022 | $19,773,000 | +37.4% | 3,041,960 | 0.0% | 0.13% | +44.8% |
| Q2 2022 | $14,388,000 | -31.3% | 3,041,960 | +1.5% | 0.09% | -20.2% |
| Q1 2022 | $20,953,000 | -30.9% | 2,997,526 | +0.8% | 0.11% | -31.0% |
| Q4 2021 | $30,313,000 | +2.1% | 2,974,762 | +22.3% | 0.16% | -1.9% |
| Q3 2021 | $29,704,000 | – | 2,432,722 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,225,000 | $20,963,000 | 8.46% |
| NORTH RUN CAPITAL, LP | 556,960 | $3,620,000 | 7.35% |
| Vitruvian Partners LLP | 5,043,356 | $32,782,000 | 5.85% |
| Casdin Capital, LLC | 10,735,786 | $69,783,000 | 4.58% |
| RIVER GLOBAL INVESTORS LLP | 1,867,113 | $11,880,000 | 2.28% |
| APIS CAPITAL ADVISORS, LLC | 200,000 | $1,300,000 | 1.95% |
| Pier Capital, LLC | 1,262,654 | $8,207,000 | 1.41% |
| Montanaro Asset Management Ltd | 929,000 | $6,009,000 | 0.92% |
| First Light Asset Management, LLC | 1,362,543 | $8,857,000 | 0.90% |
| Grandeur Peak Global Advisors, LLC | 1,206,013 | $7,839,000 | 0.48% |